CS235301B2 - Method of complex 2,2-disubstituted 1,3-platinous alkanediamine production - Google Patents
Method of complex 2,2-disubstituted 1,3-platinous alkanediamine production Download PDFInfo
- Publication number
- CS235301B2 CS235301B2 CS794751A CS475179A CS235301B2 CS 235301 B2 CS235301 B2 CS 235301B2 CS 794751 A CS794751 A CS 794751A CS 475179 A CS475179 A CS 475179A CS 235301 B2 CS235301 B2 CS 235301B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- formula
- group
- carbon atoms
- water
- compounds
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 10
- 238000004519 manufacturing process Methods 0.000 title description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 11
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract 3
- 150000001875 compounds Chemical class 0.000 claims description 37
- 239000000243 solution Substances 0.000 claims description 20
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 6
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 claims description 5
- 229910021612 Silver iodide Inorganic materials 0.000 claims description 5
- 229940045105 silver iodide Drugs 0.000 claims description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 4
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 2
- 229910002651 NO3 Inorganic materials 0.000 claims description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 2
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 239000012736 aqueous medium Substances 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 150000002690 malonic acid derivatives Chemical class 0.000 claims description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 229910021653 sulphate ion Inorganic materials 0.000 claims 2
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- 239000000460 chlorine Substances 0.000 abstract description 22
- 239000001257 hydrogen Substances 0.000 abstract description 6
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 6
- 125000003118 aryl group Chemical group 0.000 abstract description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract description 3
- 229910052801 chlorine Inorganic materials 0.000 abstract 4
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 3
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 abstract 1
- 125000000129 anionic group Chemical group 0.000 abstract 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 30
- 201000011510 cancer Diseases 0.000 description 14
- 206010028980 Neoplasm Diseases 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- -1 but not limited to Chemical class 0.000 description 7
- 231100000417 nephrotoxicity Toxicity 0.000 description 7
- 229910052697 platinum Inorganic materials 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 6
- 231100000331 toxic Toxicity 0.000 description 6
- 230000002588 toxic effect Effects 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical group OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229910001961 silver nitrate Inorganic materials 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 208000028018 Lymphocytic leukaemia Diseases 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 229910021607 Silver chloride Inorganic materials 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 2
- 125000003963 dichloro group Chemical group Cl* 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 208000003747 lymphoid leukemia Diseases 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XZVBUSAPGMMCSW-UHFFFAOYSA-L 2-amino-3-methyl-4h-imidazol-5-one;dichloroplatinum Chemical compound Cl[Pt]Cl.CN1CC(=O)N=C1N.CN1CC(=O)N=C1N XZVBUSAPGMMCSW-UHFFFAOYSA-L 0.000 description 1
- 101710134784 Agnoprotein Proteins 0.000 description 1
- 101100126625 Caenorhabditis elegans itr-1 gene Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical class NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 240000002129 Malva sylvestris Species 0.000 description 1
- 235000006770 Malva sylvestris Nutrition 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- WDLRUFUQRNWCPK-UHFFFAOYSA-N Tetraxetan Chemical compound OC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1 WDLRUFUQRNWCPK-UHFFFAOYSA-N 0.000 description 1
- ZYDVNTYVDVZMKF-UHFFFAOYSA-N [Cl].[Ag] Chemical compound [Cl].[Ag] ZYDVNTYVDVZMKF-UHFFFAOYSA-N 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940045985 antineoplastic platinum compound Drugs 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000007942 carboxylates Chemical group 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 150000001805 chlorine compounds Chemical group 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- CCQPAEQGAVNNIA-UHFFFAOYSA-N cyclobutane-1,1-dicarboxylic acid Chemical compound OC(=O)C1(C(O)=O)CCC1 CCQPAEQGAVNNIA-UHFFFAOYSA-N 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 229940125753 fibrate Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 150000002496 iodine Chemical class 0.000 description 1
- 125000003010 ionic group Chemical group 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 150000003057 platinum Chemical class 0.000 description 1
- 150000003058 platinum compounds Chemical class 0.000 description 1
- HRGDZIGMBDGFTC-UHFFFAOYSA-N platinum(2+) Chemical compound [Pt+2] HRGDZIGMBDGFTC-UHFFFAOYSA-N 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- YPNVIBVEFVRZPJ-UHFFFAOYSA-L silver sulfate Chemical compound [Ag+].[Ag+].[O-]S([O-])(=O)=O YPNVIBVEFVRZPJ-UHFFFAOYSA-L 0.000 description 1
- 229910000367 silver sulfate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- ORXDFZVXVSSTPU-UHFFFAOYSA-J tetrapotassium tetrachloride Chemical compound [Cl-].[Cl-].[Cl-].[Cl-].[K+].[K+].[K+].[K+] ORXDFZVXVSSTPU-UHFFFAOYSA-J 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000816 toxic dose Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS831229A CS235310B2 (cs) | 1978-07-06 | 1983-02-23 | Způsob výroby komplexního 2,2-disubstituovaného 1,3-alkandiaminu plstnatého |
| CS831230A CS235311B2 (cs) | 1978-07-06 | 1983-02-23 | Způsob výroby komplexního 2,2-disubstituovaného 1,3-alkandiaminu platnatého |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL7807334A NL7807334A (nl) | 1978-07-06 | 1978-07-06 | Platina-diaminecomplexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een genees- middel met toepassing van een dergelijk platina-dia- minecomplex voor de behandeling van kanker, alsmede al- dus verkregen gevormd geneesmiddel. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS235301B2 true CS235301B2 (en) | 1985-05-15 |
Family
ID=19831207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS794751A CS235301B2 (en) | 1978-07-06 | 1979-07-05 | Method of complex 2,2-disubstituted 1,3-platinous alkanediamine production |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US4410544A (es) |
| JP (1) | JPS5513280A (es) |
| AR (1) | AR226709A1 (es) |
| AT (1) | AT377251B (es) |
| AU (1) | AU533539B2 (es) |
| BE (1) | BE877527A (es) |
| CA (1) | CA1152088A (es) |
| CH (2) | CH649525A5 (es) |
| CS (1) | CS235301B2 (es) |
| CY (1) | CY1320A (es) |
| DD (1) | DD144780A5 (es) |
| DE (1) | DE2927056A1 (es) |
| DK (1) | DK153540C (es) |
| ES (3) | ES482240A1 (es) |
| FI (1) | FI76350C (es) |
| FR (2) | FR2430406A1 (es) |
| GB (1) | GB2024823B (es) |
| GR (1) | GR69248B (es) |
| HK (1) | HK9986A (es) |
| HU (1) | HU183014B (es) |
| IE (1) | IE48519B1 (es) |
| IL (1) | IL57717A (es) |
| IT (1) | IT1122011B (es) |
| KE (1) | KE3590A (es) |
| LU (1) | LU81470A1 (es) |
| MY (1) | MY8600400A (es) |
| NL (1) | NL7807334A (es) |
| NO (1) | NO163898C (es) |
| NZ (1) | NZ190923A (es) |
| PH (1) | PH21386A (es) |
| PT (1) | PT69877A (es) |
| SE (1) | SE7905927L (es) |
| SG (1) | SG91685G (es) |
| SU (2) | SU1160937A3 (es) |
| YU (1) | YU41652B (es) |
| ZA (1) | ZA793394B (es) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8204067A (nl) * | 1982-10-21 | 1984-05-16 | Tno | Platina-diaminecomplexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmiddel met toepassing van een dergelijk platinadiaminecomplex voor de behandeling van kanker, alsmede aldus verkregen gevormd geneesmiddel. |
| JPS56154493A (en) * | 1980-04-30 | 1981-11-30 | Shionogi & Co Ltd | Novel platinum complex |
| AU538863B2 (en) * | 1980-05-27 | 1984-08-30 | Bristol-Myers Company | Platinum complex salts have anti-tumor property |
| JPS5716895A (en) * | 1980-07-05 | 1982-01-28 | Otsuka Chem Co Ltd | Platinum 2 complex and antitumor agent containing the same as active principle |
| NL8101026A (nl) * | 1981-03-03 | 1982-10-01 | Tno | Platinadiamine-complexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmiddel met toepassing van een dergelijk platinadiamine-complex voor de behandeling van kanker alsmede aldus verkregen gevormd geneesmiddel. |
| JPS57156416A (en) * | 1981-03-24 | 1982-09-27 | Otsuka Chem Co Ltd | Platinum (2) complex and antitumor agent comprising it as active ingredient |
| US4786725A (en) * | 1982-06-28 | 1988-11-22 | Engelhard Corporation | Solubilized platinum (II) complexes |
| DE3305248C2 (de) * | 1983-02-16 | 1987-04-09 | Degussa Ag, 6000 Frankfurt | Verfahren zur Reinigung von cis-Platin-(II)-diammin-dichlorid |
| US4598091A (en) * | 1983-02-18 | 1986-07-01 | Degussa Aktiengesellschaft | (1,2-diphenyl)-ethylenediamine)-platinum (II) complex compounds |
| US4565884A (en) * | 1983-05-10 | 1986-01-21 | Andrulis Research Corporation | Bis-platinum complexes as antitumor agents |
| AU558747B2 (en) * | 1983-05-10 | 1987-02-05 | Andrulis Research Corporation | Bis-platinum complexes as antitumor agents |
| US4720504A (en) * | 1983-05-10 | 1988-01-19 | Andrulis Research Corporation | Use of bis-platinum complexes as antitumor agents |
| US4661516A (en) * | 1983-06-20 | 1987-04-28 | Research Corporation | Diaminocyclohexane platinum complexes |
| US4758588A (en) * | 1983-06-20 | 1988-07-19 | Research Corporation Technologies | Diaminocyclohexane platinum complexes |
| US4562275A (en) * | 1984-03-23 | 1985-12-31 | Bristol-Myers Co. | Antitumor platinum complexes |
| US4952676A (en) * | 1984-06-27 | 1990-08-28 | Johnson Matthey Plc | Monoclonal antibody-platinum co-ordination compound complex |
| EP0169645A1 (en) * | 1984-06-27 | 1986-01-29 | Johnson Matthey Public Limited Company | Platinum co-ordination compounds |
| DE3432320A1 (de) * | 1984-09-03 | 1986-03-13 | Behringwerke Ag, 3550 Marburg | Cis-platin-komplexe mit einem pentaerythritderivat als liganden, verfahren zu ihrer herstellung und diese verbindungen enthaltendes pharmazeutisches mittel |
| HU193809B (en) * | 1984-09-12 | 1987-12-28 | Chugai Pharmaceutical Co Ltd | Process for producing new platinum complexes |
| US4665210A (en) * | 1984-12-17 | 1987-05-12 | American Cyanamid Company | Platinum complexes of aliphatic tricarboxylic acids |
| US4739087A (en) * | 1985-01-10 | 1988-04-19 | Bristol-Myers Company | Antineoplastic platinum complexes |
| US4567285A (en) * | 1985-07-10 | 1986-01-28 | Yoshinori Kidani | Complex compounds of platinum |
| JPS6345290A (ja) * | 1985-08-27 | 1988-02-26 | Nippon Kayaku Co Ltd | 新規白金錯体 |
| US4737589A (en) * | 1985-08-27 | 1988-04-12 | Nippon Kayaku Kabushiki Kaisha | Platinum Complexes |
| US5116831A (en) * | 1985-12-24 | 1992-05-26 | Warner-Lambert Company | Aminoalkyl-substituted cycloalkylamine platinum (II) complexes |
| US4970324A (en) * | 1985-12-24 | 1990-11-13 | Hoeschele James D | Aminoalkyl-substituted azetidine platinum(II) complexes |
| US4880790A (en) * | 1986-01-31 | 1989-11-14 | American Cyanamid Company | (Gem-heterocyclodimethanamine-N,N')platinum complexes |
| US4760157A (en) * | 1986-01-31 | 1988-07-26 | American Cyanamid Company | (2,2,-bis(aminomethyl)-1,3-propanediol-N,N')platinum complexes |
| US4716157A (en) * | 1986-03-20 | 1987-12-29 | American Cyanamid Company | Heterocyclic-1,2-diamine platinum complexes |
| JPH05345792A (ja) * | 1986-07-01 | 1993-12-27 | Nippon Kayaku Co Ltd | 新規白金錯体 |
| DE3630497A1 (de) * | 1986-09-08 | 1988-03-10 | Behringwerke Ag | Cis-platin-komplexe, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel |
| JPS63203692A (ja) * | 1987-02-19 | 1988-08-23 | Nippon Kayaku Co Ltd | 新規白金錯体 |
| US4870070A (en) * | 1987-08-10 | 1989-09-26 | American Cyanamid Company | Water soluble platinum complexes of novel malonate derivatives |
| AT390065B (de) * | 1987-10-08 | 1990-03-12 | Behringwerke Ag | Cis-platin-komplexe, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel |
| ES2054778T3 (es) * | 1988-01-09 | 1994-08-16 | Asta Medica Ag | Complejos de 1,2-bis (aminometil) ciclobutano-platino. |
| NL8802150A (nl) * | 1988-08-31 | 1990-03-16 | Tno | Platina-(ii)-diaminecomplex, werkwijze voor het bereiden van deze verbinding, preparaat met anti-tumor werking, dat deze verbinding bevat, alsmede gevormde preparaten met anti-tumor werking. |
| NL8802149A (nl) * | 1988-08-31 | 1990-03-16 | Tno | Platina-(iv)diaminecomplex, werkwijze voor het bereiden van deze verbinding, preparaat met anti-tumor werking, dat ten minste een platinaverbinding bevat, alsmede gevormde preparaten met anti-tumor werking. |
| US4895960A (en) * | 1989-01-23 | 1990-01-23 | University Of Cincinnati | Cyclo substituted propyleneamine oxime and its use as a brain imaging agent |
| JPH0776230B2 (ja) * | 1992-01-13 | 1995-08-16 | 田中貴金属工業株式会社 | 白金化合物の製造方法 |
| DE4415263C1 (de) * | 1994-04-15 | 1995-11-30 | Asta Medica Ag | Cis-[trans-1,2-Cyclobutanbis(methylamin)-N,N']-[(2S)-lactato-O·1·, O·2·]-platin(II)-trihydrat (Lobaplatin-Trihydrat), seine Herstellung und arzneiliche Verwendung |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1432562A (en) * | 1972-04-10 | 1976-04-22 | Rustenburg Platinum Mines Ltd | Platinum co-ordination compounds |
| GB1432563A (en) * | 1972-04-10 | 1976-04-22 | Rustenburg Platinum Mines Ltd | Platinum- co-ordination compounds |
| CH605550A5 (es) * | 1972-06-08 | 1978-09-29 | Research Corp | |
| JPS5829957B2 (ja) * | 1977-09-12 | 1983-06-25 | 喜徳 喜谷 | 新規な白金錯体 |
-
1978
- 1978-07-06 NL NL7807334A patent/NL7807334A/xx not_active Application Discontinuation
-
1979
- 1979-07-03 CY CY1320A patent/CY1320A/xx unknown
- 1979-07-03 GB GB7923073A patent/GB2024823B/en not_active Expired
- 1979-07-04 IL IL57717A patent/IL57717A/xx not_active IP Right Cessation
- 1979-07-04 IT IT24099/79A patent/IT1122011B/it active
- 1979-07-04 DE DE19792927056 patent/DE2927056A1/de active Granted
- 1979-07-04 HU HU79NE613A patent/HU183014B/hu not_active IP Right Cessation
- 1979-07-05 FI FI792127A patent/FI76350C/fi not_active IP Right Cessation
- 1979-07-05 JP JP8448979A patent/JPS5513280A/ja active Granted
- 1979-07-05 NO NO792240A patent/NO163898C/no unknown
- 1979-07-05 GR GR59517A patent/GR69248B/el unknown
- 1979-07-05 AT AT0469079A patent/AT377251B/de not_active IP Right Cessation
- 1979-07-05 ES ES482240A patent/ES482240A1/es not_active Expired
- 1979-07-05 LU LU81470A patent/LU81470A1/fr unknown
- 1979-07-05 FR FR7917524A patent/FR2430406A1/fr active Granted
- 1979-07-05 CS CS794751A patent/CS235301B2/cs unknown
- 1979-07-05 NZ NZ190923A patent/NZ190923A/xx unknown
- 1979-07-05 CA CA000331212A patent/CA1152088A/en not_active Expired
- 1979-07-05 PT PT69877A patent/PT69877A/pt not_active IP Right Cessation
- 1979-07-05 DK DK284979A patent/DK153540C/da not_active IP Right Cessation
- 1979-07-05 AU AU48679/79A patent/AU533539B2/en not_active Ceased
- 1979-07-06 BE BE0/196165A patent/BE877527A/nl not_active IP Right Cessation
- 1979-07-06 ZA ZA793394A patent/ZA793394B/xx unknown
- 1979-07-06 CH CH5787/83A patent/CH649525A5/de not_active IP Right Cessation
- 1979-07-06 DD DD79214180A patent/DD144780A5/de unknown
- 1979-07-06 CH CH636579A patent/CH641758A5/de not_active IP Right Cessation
- 1979-07-06 YU YU1662/79A patent/YU41652B/xx unknown
- 1979-07-06 SU SU792788104A patent/SU1160937A3/ru active
- 1979-07-06 SE SE7905927A patent/SE7905927L/ unknown
- 1979-08-08 IE IE1271/79A patent/IE48519B1/en not_active IP Right Cessation
-
1980
- 1980-04-16 ES ES490630A patent/ES8101080A1/es not_active Expired
- 1980-04-16 ES ES490629A patent/ES8101079A1/es not_active Expired
- 1980-11-24 AR AR283341A patent/AR226709A1/es active
-
1981
- 1981-07-27 US US06/287,531 patent/US4410544A/en not_active Expired - Fee Related
- 1981-08-04 PH PH26006A patent/PH21386A/en unknown
-
1982
- 1982-09-14 FR FR8215536A patent/FR2511685B1/fr not_active Expired
-
1983
- 1983-05-04 SU SU833585700A patent/SU1414850A1/ru active
-
1985
- 1985-12-02 SG SG916/85A patent/SG91685G/en unknown
- 1985-12-06 KE KE3590A patent/KE3590A/xx unknown
-
1986
- 1986-02-05 HK HK99/86A patent/HK9986A/xx unknown
- 1986-12-30 MY MY400/86A patent/MY8600400A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS235301B2 (en) | Method of complex 2,2-disubstituted 1,3-platinous alkanediamine production | |
| EP0001126A1 (en) | Cis-platinum (II) complexes of 1,2-diamino-cyclohexane and pharmaceutical composition containing them | |
| CS239911B2 (en) | Processing of complexed diamino platinum | |
| DE2845371A1 (de) | Platinkomplexverbindung, pharmazeutische stoffzusammensetzung mit einer solchen verbindung und deren anwendung | |
| JPH0354117B2 (es) | ||
| Emen et al. | Synthesis, Characterization and Antimicrobial Activities of Some Metal Complexes with N-(2-Chloro-benzoyl) thiourea Ligands: The Crystal Structure of fac-[CoL~ 3] and cis-[PdL~ 2] | |
| CS242888B2 (en) | Method of diamminoplatinous complexes production | |
| CN112533907B (zh) | 具有新型结构的化合物、包含其的络合物、抗癌用药学组合物以及抗癌剂 | |
| Bacchi et al. | Verstile ligand behaviour of phenyl 2-pyridyl ketone benzoylhydrazone in palladium (II) complexes | |
| Tarafder et al. | Coordination chemistry and biological activity of bidentate and quadridentate nitrogen–sulfur donor ligands and their complexes | |
| FR2459247A1 (fr) | Complexe de cis-ascorbate de platine (ii) amine | |
| JP3015879B1 (ja) | 金属錯体、抗菌材、抗菌性物品、及び該物品の製造方法 | |
| CS235311B2 (cs) | Způsob výroby komplexního 2,2-disubstituovaného 1,3-alkandiaminu platnatého | |
| EP0304566A2 (en) | Water soluble platinum complexes of novel malonate derivatives | |
| JPH0450312B2 (es) | ||
| WO2009150448A1 (en) | Improvements in platinum compounds preparation by use of tetrabutylammounium amminetrichloroplatinate as intermediate | |
| CA1196004A (en) | Platinum-diamine complexes, a method for the preparation thereof, a method for the preparation of a medicine using such a platinum-diamine complex for the treatment of cancer as well as a medicine thus formed | |
| US4797485A (en) | Platinum-flavin anti-tumor complexes | |
| Verdicchio | Pyrazolone-based metal complexes: synthesis, characterization and theoretical study of Zn (II), Cu (II) and Mo (IV) derivatives | |
| CN113307829A (zh) | 一种以异羟肟酸衍生物为配体的铂(ii)配合物及其制备方法和应用 | |
| CA1097670A (en) | Compositions containing platinum | |
| CN118561920A (zh) | 单功能ons供体配体钌(ii)伞花烃配合物及其制备方法与应用 | |
| JPH0689010B2 (ja) | ジ−μ−ヒドロキソ白金（ＩＩ）二核錯体硝酸塩の製造方法 | |
| JPS5988499A (ja) | 白金−ジアミン錯体 | |
| JPH0247998B2 (ja) | Hatsukinsakutai |